Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318331 | SCV000851718 | likely benign | Inborn genetic diseases | 2017-05-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000863965 | SCV001004701 | likely benign | Familial focal epilepsy with variable foci | 2024-09-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001585684 | SCV001811284 | likely benign | not provided | 2020-06-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001585684 | SCV004154904 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | DEPDC5: BP4, BP7 |
Prevention |
RCV003953287 | SCV004767100 | likely benign | DEPDC5-related disorder | 2021-09-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |